The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $123.91

Today's change+2.19 +1.80%
Updated January 19 4:01 PM EST. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $123.91

Today's change+2.19 +1.80%
Updated January 19 4:01 PM EST. Delayed by at least 15 minutes.

Edwards Lifesciences Corp Hits New 52-week High

Edwards Lifesciences Corp closed up sharply Friday, rallying (U.S.)$2.19 or 1.80% to (U.S.)$123.91 and setting a new 52-week high. Over the last five days, shares have gained 2.55% and outperformed the S&P 500 index over the last 52 weeks with a 28.68% increase in price.

Key company metrics

  • Open(U.S.) $122.05
  • Previous close(U.S.) $121.72
  • High(U.S.) $124.10
  • Low(U.S.) $121.86
  • Bid / Ask-- / --
  • YTD % change+9.94%
  • Volume1,255,480
  • Average volume (10-day)1,183,607
  • Average volume (1-month)1,327,283
  • Average volume (3-month)1,462,216
  • 52-week range(U.S.) $86.55 to (U.S.) $124.10
  • Beta0.61
  • Trailing P/E36.02×
  • P/E 1 year forward32.91×
  • Forward PEG2.01×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.44
Updated January 19 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue822842884768
Total other revenue--------
Total revenue822842884768
Gross profit608631668555
Total cost of revenue213211216213
Total operating expense610636590567
Selling / general / administrative245244230234
Research & development143134129115
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2439105
Other operating expenses, total-112-40
Operating income212206294200
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax212206294200
Income after tax170186230159
Income tax, total42206342
Net income170186230159
Total adjustments to net income--------
Net income before extra. items170186230159
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items170186230159
Inc. avail. to common incl. extra. items170186230159
Diluted net income170186230159
Dilution adjustment--------
Diluted weighted average shares216216216218
Diluted EPS excluding extraordinary itemsvalue per share0.790.861.060.73
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.881.031.100.74